Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,850 | -15,846 | -2,603 | -2,210 | -13,860 |
| Depreciation Amortization | 579 | 688 | 754 | 969 | 990 |
| Accounts receivable | -1,385 | 2,106 | -1,626 | -398 | 0 |
| Accounts payable and accrued liabilities | 2,859 | -165 | -1,294 | -1,942 | 0 |
| Other Working Capital | 2,558 | 2,298 | -2,139 | -2,944 | 3,690 |
| Other Operating Activity | -704 | -1,248 | 3,320 | 2,377 | 1,690 |
| Operating Cash Flow | $-12,944 | $-12,167 | $-3,588 | $-4,148 | $-7,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -808 | -189 | 4,104 | -109 | -260 |
| Purchase Sale Intangibles | N/A | N/A | -525 | -100 | 0 |
| Other Investing Activity | 0 | 0 | -525 | -100 | -4,620 |
| Investing Cash Flow | $-808 | $-189 | $3,579 | $-209 | $-4,880 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,210 | N/A | N/A | N/A | 0 |
| Debt Repayment | -3,373 | N/A | N/A | N/A | 0 |
| Common Stock Issued | 11,962 | 9,038 | 5,892 | 149 | 0 |
| Dividend Paid | -188 | -202 | -218 | -410 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 6,373 | 10,350 |
| Financing Cash Flow | $14,611 | $8,836 | $5,674 | $6,113 | $10,350 |
| Exchange Rate Effect | 98 | -14 | -52 | -90 | 70 |
| Beginning Cash Position | 4,061 | 7,595 | 1,982 | 315 | 2,250 |
| End Cash Position | 5,018 | 4,061 | 7,595 | 1,982 | 310 |
| Net Cash Flow | $958 | $-3,534 | $5,613 | $1,667 | $-1,940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,944 | -12,167 | -3,588 | -4,148 | -7,490 |
| Capital Expenditure | -808 | -189 | -16 | -109 | 0 |
| Free Cash Flow | -13,752 | -12,356 | -3,604 | -4,257 | -7,490 |